Treato

Treato was an Israeli health-data analytics company focused on extracting and organizing health-related insights from online patient and caregiver discussions. Established in 2007 as a research and development venture, the company was headquartered in Or Yehuda and later developed a commercial presence in the United States, including offices in New York City and Princeton, New Jersey. Its business addressed several audiences within healthcare: patients and caregivers seeking information, healthcare professionals and hospitals looking for broader perspectives on treatment experiences, and pharmaceutical companies and healthcare marketing organizations seeking structured intelligence from online health conversations. Treato's consumer-facing service functioned as a searchable online portal covering medications, medical conditions, and treatments. Its broader commercial proposition involved turning large volumes of publicly available or socially generated health discussion into data products and analytical services. These offerings were positioned for pharmaceutical and healthcare organizations that wanted to understand patient experience, treatment perceptions, medication discussions, and unmet informational needs. The company's products and services were commonly described as health-data assets and IQ services rather than as conventional clinical-care products. Treato began making its commercial offering available in 2011, expanding beyond its Israeli research base through its American offices. This period reflected the company's attempt to build an international healthcare-information and analytics business around the growing quantity of health discussion taking place online. Its model sat at the intersection of digital health, social-media intelligence, patient engagement, and pharmaceutical market research. The company ultimately did not achieve a sustainable financial outcome. Treato shut down in August 2018 after failing to secure sufficient additional funding or an acquisition offer. It remained in a state of insolvency following the closure. As a result, Treato is no longer an operating health-information platform or analytics provider. Its historical significance lies in its early effort to convert online patient-generated discussion into structured intelligence for both consumers and healthcare organizations.

Treato was founded in 2007 in Israel as a research and development company. Its headquarters were established in Or Yehuda, placing the business within Israel's technology and digital-health ecosystem. From the outset, Treato concentrated on health-related information and the possibility of using online patient and caregiver conversations as a source of insight. Rather than operating primarily as a healthcare provider, it developed an information and analytics model designed to organize treatment-related discussion for consumers and commercial healthcare users. The company's central concept was to make online health conversations searchable and analytically useful. Its portal allowed users to look for information about medications, health conditions, and medical treatments. This consumer service addressed the difficulty patients and caregivers often faced when trying to find practical accounts and broader perspectives beyond formal product or clinical information. At the same time, the underlying data was relevant to healthcare professionals, hospitals, pharmaceutical companies, and healthcare marketing and advertising agencies. Treato moved from research and development into commercial availability in 2011. It established offices in New York City and Princeton, New Jersey, indicating an effort to serve the United States market and to develop relationships with pharmaceutical and healthcare organizations there. Its commercial portfolio included health-data assets and services described as Treato IQ. These offerings were intended to help healthcare organizations interpret patient-related online discussion and derive insights concerning medications, conditions, and treatment experiences. Treato's business belonged to an early wave of digital-health and social-health-information companies seeking to transform user-generated content into structured intelligence. Its model combined a public-facing information portal with business-to-business data and analytics services. For pharmaceutical companies and agencies, the potential value lay in observing patient perspectives and treatment conversations at scale; for patients and caregivers, the portal offered a way to discover health information through a dedicated search experience. Despite developing a commercial offering and maintaining operations in Israel and the United States, Treato did not secure a durable financial path. In August 2018, the company shut down after failing to raise sufficient funding or obtain an acquisition offer. It remained in insolvency after ceasing operations. Treato is therefore a defunct company rather than an active consumer-health or analytics brand. Publicly available reference material does not establish a successor company, continuing owner, acquisition, or later relaunch.

• 2018

  Operations cease

  [1]Treatoen.wikipedia.org

  Treato shut down in August after failing to secure enough funding or an acquisition offer and remained insolvent.

• 2011

  Commercial offering begins

  [1]Treatoen.wikipedia.org

  Treato began making its health-information and analytics offering commercially available and developed offices in New York City and Princeton, New Jersey.

• 2007

  Treato is founded in Israel

  [1]Treatoen.wikipedia.org

  Treato was established as a research and development company with headquarters in Or Yehuda, Israel.

Treato positioned itself as a health-data and patient-insight company, combining a searchable consumer health portal with analytics products for pharmaceutical companies, healthcare agencies, hospitals, healthcare professionals, and other healthcare organizations.

• Consumer health information · 2011

  Treato online health-information portal

  Treato's online portal provided a searchable environment for information about medications, health conditions, and medical treatments. It was intended for patients and caregivers seeking health-related perspectives and also supported the company's broader data proposition. The portal formed the consumer-facing part of Treato's business, complementing its commercial analytics and information services for healthcare organizations.

• Healthcare analytics · 2011

  Treato IQ

  Treato IQ referred to the company's commercial intelligence and analytical services built around health-related online discussion. These services were aimed at pharmaceutical companies, healthcare marketing and advertising agencies, hospitals, healthcare professionals, and other healthcare organizations. The offering sought to turn patient- and caregiver-generated information concerning medicines, conditions, and treatments into usable health-data assets and insights.

• 2018

  Company shuts down after funding and acquisition efforts failStrategy

  Background

  Treato's health-data analytics business had expanded into commercial services and the United States, but the company was unable to secure sufficient funding or an acquisition offer.

  Action taken

  Treato ceased operations in August 2018 and entered a state of insolvency.

  Aftermath

  The Treato platform and commercial services were discontinued. No successor, acquisition, or relaunch is identified in the available reference material.

  Source

1. 1Treatoen.wikipedia.org